Czech National Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.6M Buy
365,443
+16,292
+5% +$1.31M 0.16% 110
2026
Q1
$30.3M Buy
349,151
+10,945
+3% +$1.05M 0.2% 95
2025
Q4
$32.5M Buy
338,206
+12,791
+4% +$1.24M 0.21% 89
2025
Q3
$31M Buy
325,415
+11,916
+4% +$1.1M 0.21% 90
2025
Q2
$27.3M Buy
313,499
+18,978
+6% +$1.61M 0.21% 93
2025
Q1
$26.5M Buy
294,521
+16,456
+6% +$1.47M 0.24% 86
2024
Q4
$22.2M Buy
278,065
+16,786
+6% +$1.45M 0.21% 94
2024
Q3
$23.5M Buy
261,279
+8,249
+3% +$694K 0.24% 80
2024
Q2
$19.9M Buy
253,030
+19,076
+8% +$1.56M 0.23% 87
2024
Q1
$20.4M Buy
233,954
+880
+0.4% +$75.1K 0.26% 79
2023
Q4
$19.2M Buy
233,074
+416
+0.2% +$31.7K 0.27% 76
2023
Q3
$18.2M Buy
232,658
+75,163
+48% +$6.29M 0.29% 71
2023
Q2
$13.9M Buy
157,495
+793
+0.5% +$68.3K 0.32% 67
2023
Q1
$12.6M Buy
156,702
+1,123
+0.7% +$91.5K 0.31% 72
2022
Q4
$12.1M Buy
155,579
+1,164
+0.8% +$94.3K 0.32% 76
2022
Q3
$12.5M Buy
+154,415
New +$13.9M 0.36% 60

Other funds holding MDT

Czech National Bank's MDT Position: Q2 2026 in Review

Czech National Bank increased its Medtronic (MDT) stake by 4.7% in Q2 2026, buying an estimated $1.31M and bringing the position to 365,443 shares worth $28.6M. The position accounts for 0.16% of the portfolio, ranked #110.

Czech National Bank first reported a position in MDT in Q3 2022 and has held it in 16 quarters since. The position peaked at $32.5M in Q4 2025. 796 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Czech National Bank held 365,443 shares of Medtronic worth $28.6M as of Q2 2026.
  • Czech National Bank bought 16,292 Medtronic shares in Q2 2026, an estimated $1.31M.
  • Medtronic made up 0.16% of Czech National Bank's portfolio in Q2 2026, its #110 holding.
  • Czech National Bank first reported a position in Medtronic in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's Medtronic position peaked at $32.5M in Q4 2025.
  • 796 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.